CN103656218A - External medicine for treating acute eczema - Google Patents
External medicine for treating acute eczema Download PDFInfo
- Publication number
- CN103656218A CN103656218A CN201310674290.3A CN201310674290A CN103656218A CN 103656218 A CN103656218 A CN 103656218A CN 201310674290 A CN201310674290 A CN 201310674290A CN 103656218 A CN103656218 A CN 103656218A
- Authority
- CN
- China
- Prior art keywords
- parts
- external medicine
- medicine
- acute eczema
- external use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to an external medicine for treating acute eczema. The external medicine for treating the acute eczema comprises the following medicinal raw materials: kadsura root-bark, edible tulip, red peony root, fructus kochiae, cantharides, radix sileris, periostracum cicada, rhizoma arisaematis, schizonepeta and common cnidium fruit. The external medicine is water decoction or paste. The external medicine is prepared through the compatibility of the various raw materials, can be used for clearing away heat, drying dampness, dispelling wind-evil and relieving internal heat or fever and has a remarkable curative effect on the acute eczema; the effective rate of the external medicine reaches above 90%.
Description
Technical field
The present invention relates to treat the medicine for external use of acute eczema.
Background technology
Acute eczema is that the inflammatory skin of the epidermis that caused by multiple inside and outside factor and high dermis is sick, has multiformity erythra and oozes out tendency, accompanies violent pruritus, easily outbreak repeatedly, and normal and allergy has certain relation.In early days or acute phase, clinical symptoms is erythema and pimple in blocks, or the vesicle that has no of naked eyes, occurs large stretch of sepage and erosion when serious.
Patient's allergic constitution is the important pathogenic factors of primary disease, relevant with heredity, can change with age, environment.Neural factors, as worried, nervous, excited, insomnia, fatigue etc., also can bring out or aggravate disease.In addition, the factor such as endocrine, metabolism, gastrointestinal dysfunction, infection focus also has relation with morbidity.
Daylight, damp and hot, be dried, scratch, the factor such as friction, cosmetics, soap, fur, fuel, staple fibre all can bring out eczema.Some food increases the weight of as the food such as fish and shrimp, egg can make eczema.
Acute eczema is the antiallergic and antipruritic medicines that adopt clinically more, generally with hormone ointment, are coated with oral anti-allergy medicine outward.Hormone medicine has certain side effect to skin, being not suitable for child and anemia of pregnant woman uses, normal adult access times too much or continuous service time is long all can produce harmful effect to skin, and hormone medicine easily produces dependency, once stop using, the state of an illness is easily recovered at once, even more serious.
Summary of the invention
Technical problem to be solved by this invention is to provide and a kind ofly has no side effect, the medicine for external use for the treatment of acute eczema evident in efficacy.
The technical scheme that the present invention solves the problems of the technologies described above is:
Treat a medicine for external use for eczema, crude drug is comprised of the component of following mass fraction: Herba Schizonepetae 20-25 part, Radix Saposhnikoviae 18-22 part, Cortex cercis chinensis 10-15 part, Pseudobulbus cremastrae seu pleiones 10-15 part, Radix Paeoniae Rubra 10-15 part, Fructus Kochiae 8-15 part, Mylabris 2-4 part, Periostracum Cicadae 8-12 part Rhizoma Arisaematis 3-7 part Fructus Cnidii 3-7 part.
The mass fraction of described crude drug is preferably: 22 parts of Herba Schizonepetae, 20 parts of Radix Saposhnikoviaes, 12 parts of Cortex cercis chinensiss, 12 parts of Pseudobulbus cremastrae seu pleiones, 12 parts of Radix Paeoniae Rubra, 8 parts of the Fructus Kochiae, 3 parts of Mylabris, 5 parts of 5 parts of Fructus Cnidiis of 10 parts of Rhizoma Arisaematiss of Periostracum Cicadae.
This medicine for external use is water decoction or unguentum.
In each raw material of the present invention, Herba Schizonepetae is dispeled the wind, induces sweat, rash; Radix Saposhnikoviae expelling pathogenic wind from the body surface, removing dampness to relieve pain, spasmolytic, antipruritic; Cortex cercis chinensis promoting blood circulation to restore menstrual flow, subduing swelling and detoxicating; Pseudobulbus cremastrae seu pleiones eliminating stagnation, blood stasis dispelling; Radix Paeoniae Rubra clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling; Fructus Kochiae diuresis, clearing away damp-heat; Mylabris nature and flavor are pungent, and heat is very toxic, have removing blood stasis eliminating mass, the function of counteracting toxic substances phagedenoma; The Periostracum Cicadae wind heat extraction that falls apart; Rhizoma Arisaematis is bitter, pungent, temperature, and poisonous, drying dampness to eliminate phlegm, expellings wind and relieving convulsion, mass dissipating and swelling eliminating; Fructus Cnidii removing dampness and killing parasites, dispelling wind for relieving itching.The various material combinations of the present invention, have significant heat clearing and damp drying, the effect of the removing toxic substances of dispeling the wind.External every day of the present invention for several times, has significant effect to eczema, and effective percentage reaches more than 90%.
The specific embodiment
Below in conjunction with embodiment, the present invention will be described in detail.
Embodiment
Treat a medicine for external use for acute eczema, crude drug is comprised of the component of following mass fraction:: 22 parts of Herba Schizonepetae, 20 parts of Radix Saposhnikoviaes, 12 parts of Cortex cercis chinensiss, 12 parts of Pseudobulbus cremastrae seu pleiones, 12 parts of Radix Paeoniae Rubra, 8 parts of the Fructus Kochiae, 3 parts of Mylabris, 5 parts of 5 parts of Fructus Cnidiis of 10 parts of Rhizoma Arisaematiss of Periostracum Cicadae.
Crude drug is made to water decoction according to a conventional method.
The present invention uses through hundreds of routine acute eczema patients, and effective percentage reaches more than 90%, and following is 3 detailed cases.
Case one
Poplar, female, one's late 30s, abdominal part both sides burst large area eczema, present at the beginning erythema in blocks, but do not take notice of, occur very soon large stretch of sepage and erosion, pruritus, after with medicine of the present invention, make water decoction, stifling while hot, after alternating temperature, clean affected part half an hour, every day 2 times, after 3 days, scratchiness disappears, and sepage and rotten to the corn symptom obviously take a turn for the better, and use continuously 10 days, it is more smooth that eczema position skin has become, and erythema is not obvious, continues to use 3 days, recovery from illness, follow-up investigation half a year, has no recurrence.
Case two
Chen, female, 28 years old, in January, 2013, face obtained eczema, and after going Hospital of Skin Diseases to see, doctor has been opened hormone ointment, has used the section time very fast normal.But recurrence again, was covered with erythema on the face every several days, violent pruritus, very uncomfortable.Because worrying that hormones ointment has side effect to facial skin, finds inventor.After with medicine of the present invention, make water decoction, stifling while hot, after alternating temperature, clean affected part half an hour, every day 2 times, after one day, scratchiness obviously alleviates, and 3 Tian Hou face erythema obviously subtract light, smooth, use continuously 10 days, recovery from illness, after three months, inventor's inquiry, has no recurrence.
Case three
Wang, man, the Spring Festival in 2013, the back lumbar part of drinking burst large area eczema, redness, unbearably, there is large stretch of sepage and erosion in pruritus, flows out yellow transudate.With medicine of the present invention, make water decoction, stifling while hot, after alternating temperature, clean affected part half an hour, every day 2 times, after one day, scratchiness obviously alleviates, sepage and rotten to the corn disappearance after 3 days, after 10 days, erythema disappears substantially, completely no longer pruritus.After continuing to use a couple of days, fully recover, do not hear recurrence.
Claims (3)
1. a medicine for external use for the treatment of acute eczema, it is characterized in that crude drug is comprised of the component of following mass fraction: Herba Schizonepetae 20-25 part, Radix Saposhnikoviae 18-22 part, Cortex cercis chinensis 10-15 part, Pseudobulbus cremastrae seu pleiones 10-15 part, Radix Paeoniae Rubra 10-15 part, Fructus Kochiae 8-15 part, Mylabris 2-4 part, Periostracum Cicadae 8-12 part Rhizoma Arisaematis 3-7 part Fructus Cnidii 3-7 part.
2. the medicine for external use for the treatment of acute eczema according to claim 1, it is characterized in that: the mass fraction of described crude drug is preferably: 22 parts of Herba Schizonepetae, 20 parts of Radix Saposhnikoviaes, 12 parts of Cortex cercis chinensiss, 12 parts of Pseudobulbus cremastrae seu pleiones, 12 parts of Radix Paeoniae Rubra, 8 parts of the Fructus Kochiae, 3 parts of Mylabris, 5 parts of 5 parts of Fructus Cnidiis of 10 parts of Rhizoma Arisaematiss of Periostracum Cicadae.
3. the medicine for external use for the treatment of acute eczema according to claim 1, is characterized in that: described medicine for external use is water decoction or unguentum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310674290.3A CN103656218B (en) | 2013-12-13 | 2013-12-13 | A kind of medicine for external use for the treatment of acute eczema |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310674290.3A CN103656218B (en) | 2013-12-13 | 2013-12-13 | A kind of medicine for external use for the treatment of acute eczema |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103656218A true CN103656218A (en) | 2014-03-26 |
| CN103656218B CN103656218B (en) | 2015-10-28 |
Family
ID=50295776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310674290.3A Expired - Fee Related CN103656218B (en) | 2013-12-13 | 2013-12-13 | A kind of medicine for external use for the treatment of acute eczema |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103656218B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105169150A (en) * | 2015-10-30 | 2015-12-23 | 江崇礼 | Traditional Chinese medicine composition for treating acute eczema |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102475813A (en) * | 2010-11-22 | 2012-05-30 | 刘宝环 | Medicament for treating eczema |
-
2013
- 2013-12-13 CN CN201310674290.3A patent/CN103656218B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102475813A (en) * | 2010-11-22 | 2012-05-30 | 刘宝环 | Medicament for treating eczema |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105169150A (en) * | 2015-10-30 | 2015-12-23 | 江崇礼 | Traditional Chinese medicine composition for treating acute eczema |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103656218B (en) | 2015-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103272199B (en) | Frostbite treatment medicine | |
| CN102614422A (en) | Traditional Chinese medical decoction for treatment of acute gouty arthritis | |
| CN102423376A (en) | Traditional Chinese medicine for treating erysipelas | |
| CN103751568B (en) | A kind of Chinese medicine composition treating pruritus and preparation method thereof | |
| CN102302733B (en) | Oral Chinese medicinal composition for treating ovarian cyst | |
| CN103656365B (en) | A kind of Chinese medicine for the treatment of the hyperthyroidism of deficiency of YIN of both the heart and liver pattern of syndrome | |
| CN103656218B (en) | A kind of medicine for external use for the treatment of acute eczema | |
| CN102716201B (en) | Preparation method of herba epimedii traditional Chinese medicine preparation for treating rheumatoid arthritis | |
| CN104740201A (en) | Traditional Chinese medicine preparation for treating ankylosing spondylitis | |
| CN104757536A (en) | Brassica rapa health-care product | |
| CN104306555A (en) | Food, health product or pharmaceutical composition for treating insomnia | |
| CN103933387A (en) | Traditional Chinese medicine preparation for treating chronic glomerulonephritis | |
| CN106334154A (en) | Traditional Chinese medicine pillow for treating neck eczema and preparation method thereof | |
| CN105250526A (en) | Traditional Chinese medicine composition for treating schizophrenia | |
| CN104055959A (en) | Traditional Chinese medicine lotion and nursing method for treating gastrointestinal dampness-heat type seborrhoeic dermatitis | |
| CN104324290A (en) | Traditional Chinese medicine composition for treating pityriasis rosea | |
| CN103599419B (en) | Traditional Chinese medicine combination for treating gout | |
| CN103191230A (en) | Traditional Chinese medicine for treating infantile recurrent hordeolum | |
| CN103599271B (en) | A kind of Chinese medicine for the treatment of hysteromyoma | |
| CN102327532B (en) | Capsule for treating rheumatism and rheumatoid arthritis | |
| CN106039270A (en) | Traditional Chinese medicine for treating Alzheimer's disease | |
| CN105194447A (en) | Traditional Chinese medicinal oral solution for treating refractory insomnia and preparation method | |
| CN105663828A (en) | Medicine for treating postnatal depression and preparation method | |
| CN105213666A (en) | Two black Lignum Pini Nodi Chinese medicinal liquor | |
| CN104873896A (en) | Traditional Chinese medicine composition for treating stroke caused by hypertension |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20151029 Address after: 516008, Ma Zhuang Road 43, Huicheng District, Guangdong, Huizhou Patentee after: Zhu Mai Address before: 516800, No. 55, Xilin Road, Longmen County, Guangdong, Huizhou Patentee before: Zhang Yingqin |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151028 Termination date: 20151213 |
|
| EXPY | Termination of patent right or utility model |